Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.
Часто задаваемые вопросы
В каком секторе работает DNA Biomed Solns (DNA)?
DNA Biomed Solns относится к сектору Информационные технологии.
Какова текущая цена акций DNA Biomed Solns (DNA)?
По последним данным, цена акций DNA Biomed Solns составляет 1,03 ₪, предыдущее закрытие — 1,03 ₪.
Выплачивает ли DNA Biomed Solns (DNA) дивиденды?
Нет, DNA Biomed Solns не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у DNA Biomed Solns (DNA)?
У компании DNA Biomed Solns бета -0.008, что указывает на более низкую волатильность по сравнению с рынком в целом.
